title: Evolving role of FDG PET/CT in multiple myeloma imaging and management.
abstract: OBJECTIVE
  Multiple myeloma is the most common cause of primary malignancy in bones. Radiography has been the imaging reference standard for decades. However, the growing use of CT, MRI, and PET technology has led to earlier diagnosis of multiple myeloma, more accurate therapy assessment, and better prediction of patient outcome. This article is focused on the evolving role of (18)F-FDG PET/CT in multiple myeloma diagnosis, therapy assessment, and prognosis.
  
  
  CONCLUSIONS
  FDG PET/CT is a valuable imaging modality in diagnosis, therapy assessment, and prognosis of multiple myeloma.
authors.affiliation: Department of Radiology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Ankit
authors.initials: A
authors.lastname: Agarwal
authors.forename: Alin
authors.initials: A
authors.lastname: Chirindel
authors.forename: Bhartesh A
authors.initials: BA
authors.lastname: Shah
authors.forename: Rathan M
authors.initials: RM
authors.lastname: Subramaniam
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18